Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
UHS · against 160 other Healthcare companies of similar size
Ranked #3 of 161 · scores higher than 99% of peers
Bars: peers in each 10-point band of the valuation score15 peers with a valuation score of 90–100, including UHS · Click a bar to see the companies
Mainly thanks to its earnings yield, EBITDA yield and free cash flow yield, which are stronger than most Healthcare peers.
| Metric | UHS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 160 reported | 13.8% | 2.5% | 99% | 30% | |
| EBITDA yieldHigher is better · 160 reported | 17.2% | 4.7% | 99% | 50% | |
| Free cash flow yieldHigher is better · 96 reported | 7.8% | 2.2% | 95% | 20% | |
| Book yieldHigher is better · 159 reported | 72.0% | 18.8% | 94% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 2 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 3 | 10.4B USD | 96 | 64 | |
| 4 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 5 | 11.6B USD | 94 | 58 | |
| 5 | 68.0B BRL (≈$12.2B) | 94 | 67 | |
| 7 | 1.09T JPY (≈$7.4B) | 93 | 75 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score